Literature DB >> 7093130

The effects of nebulized salbutamol on lung function and exercise tolerance in patients with severe airflow obstruction.

S J Connellan, S E Gough.   

Abstract

The effects of 10 mg of nebulized salbutamol on lung mechanics and exercise tolerance in 10 patients with severe airflow obstruction are described. All patients were previously considered to have irreversible airflow obstruction as demonstrated by little or no improvement in expiratory flow rates either during a corticosteroid trial or after inhalation of 100 micrograms of isoprenaline. There was a small improvement in expiratory flow rate after nebulized salbutamol but the greatest increases were seen in slow vital capacity, inspiratory capacity, inspiratory flow rates, dynamic compliance during tidal breathing, mid-inspiratory and expiratory pulmonary resistance and exercise tolerance. The mechanism of these effects and their therapeutic significance is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7093130

Source DB:  PubMed          Journal:  Br J Dis Chest        ISSN: 0007-0971


  8 in total

1.  Reproducibility of walking test results in chronic obstructive airways disease.

Authors:  A J Knox; J F Morrison; M F Muers
Journal:  Thorax       Date:  1988-05       Impact factor: 9.139

2.  Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease.

Authors:  A Grove; B J Lipworth; P Reid; R P Smith; L Ramage; C G Ingram; R J Jenkins; J H Winter; D P Dhillon
Journal:  Thorax       Date:  1996-07       Impact factor: 9.139

3.  Use of oxygen driven nebulizer delivery systems for beta-2 agonists in chronic bronchitis.

Authors:  D O'Donnell; C P Kelly; P Cotter; L Clancy
Journal:  Ir J Med Sci       Date:  1985-05       Impact factor: 1.568

4.  Effect of nebulised salbutamol on maximal exercise performance in men with mild asthma.

Authors:  W Freeman; G E Packe; R M Cayton
Journal:  Thorax       Date:  1989-11       Impact factor: 9.139

5.  Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease.

Authors:  D M Newnham; D P Dhillon; J H Winter; C M Jackson; R A Clark; B J Lipworth
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

6.  Dose response to inhaled salbutamol in chronic obstructive airways disease.

Authors:  C Teale; J F Morrison; R L Page; S B Pearson
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

7.  Dose-response study of inhaled salbutamol powder in chronic airflow obstruction.

Authors:  P A Corris; E Neville; S Nariman; G J Gibson
Journal:  Thorax       Date:  1983-04       Impact factor: 9.139

8.  A comparison of the effects of prednisolone and mianserin on ventilatory, exercise and psychometric parameters in patients with chronic obstructive pulmonary disease.

Authors:  A Grove; B J Lipworth; C G Ingram; R A Clark; D P Dhillon
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.